Bonus BioGroup says its innovative use of mesenchymal stromal cells offers a protection layer for patients prone to respiratory distress.

Yael Zilberman-Simakov has developed a technology for heart patients allowing them to monitor the risk of heart failure with a prick of the finger, in the same way diabetics do.